Seven Eight Capital buys $3,008,150 stake in Monsanto Company (MON)

Monsanto Company (MON) : Seven Eight Capital scooped up 12,900 additional shares in Monsanto Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 12, 2016. The investment management firm now holds a total of 28,581 shares of Monsanto Company which is valued at $3,008,150.Monsanto Company makes up approximately 0.99% of Seven Eight Capital’s portfolio.

Other Hedge Funds, Including , Group One Trading boosted its stake in MON in the latest quarter, The investment management firm added 79,327 additional shares and now holds a total of 111,072 shares of Monsanto Company which is valued at $11,690,328. Monsanto Company makes up approx 1.02% of Group One Trading’s portfolio.Aberdeen Asset Management Plcuk reduced its stake in MON by selling 106,677 shares or 19.78% in the most recent quarter. The Hedge Fund company now holds 432,685 shares of MON which is valued at $45,155,007. Monsanto Company makes up approx 0.16% of Aberdeen Asset Management Plcuk’s portfolio. Fox Run Management L.l.c. sold out all of its stake in MON during the most recent quarter. The investment firm sold 9,900 shares of MON which is valued $1,056,924.Acropolis Investment Management reduced its stake in MON by selling 314 shares or 8.96% in the most recent quarter. The Hedge Fund company now holds 3,192 shares of MON which is valued at $339,756. Monsanto Company makes up approx 0.06% of Acropolis Investment Management’s portfolio.

Monsanto Company opened for trading at $107.86 and hit $108.26 on the upside on Monday, eventually ending the session at $107.54, with a gain of 0.13% or 0.14 points. The heightened volatility saw the trading volume jump to 24,26,569 shares. Company has a market cap of $47,057 M.

On the company’s financial health, Monsanto Company reported $2.17 EPS for the quarter, missing the analyst consensus estimate by $ -0.23 based on the information available during the earnings call on Jun 29, 2016. Analyst had a consensus of $2.40. The company had revenue of $4189.00 million for the quarter, compared to analysts expectations of $4487.57 million. The company’s revenue was down -8.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $2.39 EPS.

Investors should note that on Aug 12, 2016, Monsanto Company announced a cash dividend of $0.5400. The company’s management has announced Oct 5, 2016 as the ex-dividend date and fixed the record date on Oct 7, 2016. The payable date has been fixed on Oct 28, 2016.

Many Wall Street Analysts have commented on Monsanto Company. Monness Crespi & Hardt Upgraded Monsanto Company on Aug 8, 2016 to ” Buy”, Price Target of the shares are set at $130.Monsanto Company was Upgraded by Jefferies to ” Buy” on May 25, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.